Lory, Philippe, 1962-...
Philippe Lory
VIAF ID: 190587120 (Personal)
Permalink: http://viaf.org/viaf/190587120
Preferred Forms
- 100 1 _ ‡a Lory, Philippe ‡d 1962-..
- 100 1 _ ‡a Lory, Philippe, ‡d 1962-...
- 100 0 _ ‡a Philippe Lory
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
The alpha1I T-type calcium channel exhibits faster gating properties when overexpressed in neuroblastoma/glioma NG 108-15 cells. | |
The beta subunit controls the gating and dihydropyridine sensitivity of the skeletal muscle Ca2+ channel | |
Blockade of T-type calcium channels prevents tonic-clonic seizures in a maximal electroshock seizure model | |
Bradycardia and slowing of the atrioventricular conduction in mice lacking CaV3.1/alpha1G T-type calcium channels | |
Ca(v)3.2 calcium channels control an autocrine mechanism that promotes neuroblastoma cell differentiation. | |
Calcium channelopathies in inherited neurological disorders: relevance to drug screening for acquired channel disorders. | |
Les canaux calciques voltage dépendantes de type L dans les interneurones de la couche moléculaire du cervelet. | |
Caractérisation et étude des régulations des canaux calciques exprimés dans l'ovocyte de xénope suite à l'injection d'ARN messagers extraits de différents tissus excitables | |
Cerebral hyperexcitability study of genetic epilepsy murine models and development of new therapeutic strategy to reduce it. | |
CHARACTERIZATION AND REGULATION STUDIES OF CALCIUM CHANNELS EXPRESSED IN XENOPUS OOCYTES FOLLOWING INJECTION OF MRNAS FROM A VARIETY OF EXCITABLE TISSUES. | |
Characterization of calcium signals generated by activation of the two excitatory synaptic inputs in Purkinje neurons. | |
Characterization of the dominant inheritance mechanism of Episodic Ataxia type 2. | |
Cross-modulation and molecular interaction at the Cav3.3 protein between the endogenous lipids and the T-type calcium channel antagonist TTA-A2. | |
Design of carrier peptide-oligonucleotide conjugates with rapid membrane translocation and nuclear localization properties | |
Development of a mouse model to study the metal/redox modulation of Cav3.2 calcium channels in neuronal excitability and in the pain pathways. | |
Développement d'une souris modèle pour l'étude de la modulation metal/redox du canal calcique Cav3.2 dans l'excitabilité neuronale et dans les voies de la douleur | |
Etude de la spécificité pharmacologique et de l'impact physiologique des canaux T | |
Étude fonctionnelle de mutations des canaux sodiques potentiel-dépendants Nav1.1 et Nav1.2 : corrélation phénotype/génotype et mise en évidence d'un mécanisme spécifique pour les troubles du spectre de l'autisme | |
Functional expression of CLIFAHDD and IHPRF pathogenic variants of the NALCN channel in neuronal cells reveals both gain- and loss-of-function properties | |
Functional properties of the α1G, α1H and α1I T-type calcium channels subunits. | |
Functional study of voltage-gated sodium channels Nav1.1 and Nav1.2 mutations : phenotype/genotype relationship and highlighting of a specific mechanism for Autism Spectrum Disorder. | |
[Genetic diversity of voltage-gated calcium channels] | |
Hallmarks of the channelopathies associated with L-type calcium channels: a focus on the Timothy mutations in Ca(v)1.2 channels. | |
Hypokalemic periodic paralysis: an autosomal dominant muscle disorder caused by mutations in a voltage-gated calcium channel. | |
The I-II loop controls plasma membrane expression and gating of Ca(v)3.2 T-type Ca2+ channels: a paradigm for childhood absence epilepsy mutations | |
Identification of new genes in syndromic recessive ataxias : involvement of moderate metabolic disorders. | |
The involvement of Cav3.2/alpha1H T-type calcium channels in excitability of mouse embryonic primary vestibular neurones. | |
Lysosomal and network alterations in human mucopolysaccharidosis type VII iPSC-derived neurons | |
Mécanismes psysiopathologiques des ataxies épisodiques et progressives associées aux canaux calciques de type P/Q | |
The molecular basis for T-type Ca2+ channel inhibition by G protein beta2gamma2 subunits. | |
[Molecular genetics of cardiovascular calcium channels] | |
Molecular pathways underlying the modulation of T-type calcium channels by neurotransmitters and hormones. | |
Mouse hippocampal phosphorylation footprint induced by generalized seizures: Focus on ERK, mTORC1 and Akt/GSK-3 pathways. | |
Myogenic tone is impaired at low arterial pressure in mice deficient in the low-voltage-activated CaV 3.1 T-type Ca(2+) channel | |
The NALCN ion channel is activated by M3 muscarinic receptors in a pancreatic beta-cell line | |
Neuronal Cav3 channelopathies: recent progress and perspectives | |
De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene | |
De novo mutations in NALCN cause a syndrome characterized by congenital contractures of the limbs and face, hypotonia, and developmental delay | |
Pathogenic Mechanisms of Cav2.1 calcium channels associated Ataxia and potential therapy approaches. | |
Pharmacological specificity and physiological impact of T type calcium channels. | |
Physiological involvement of presynaptic L-type voltage dependent calcium channels in GABA release of cerebellar molecular layer interneurons | |
[Physiopathology of calcium channels: identification of calcium channelopathies] | |
Plasma membrane expression of T-type calcium channel alpha(1) subunits is modulated by high voltage-activated auxiliary subunits. | |
Propriétés fonctionnelles des sous-unités α1G, α1H et α1I des canaux calciques de type T | |
A Recurrent Mutation in CACNA1G Alters Cav3.1 T-Type Calcium-Channel Conduction and Causes Autosomal-Dominant Cerebellar Ataxia | |
Régulation de l'assemblage et de l'activité des canaux potassiques de type K2P | |
Regulation of the assembly and activity of K2P potassium channels. | |
RNAi silencing of P/Q-type calcium channels in Purkinje neurons of adult mouse leads to episodic ataxia type 2. | |
Rôle du zinc dans la transmission synaptique normale et pathologique | |
Setting a cellular model to functionnally explore the ion channel NALCN activity : characterization of human NALCN leak current and differents mutants in a pathological context. | |
The sodium leak channel, NALCN, in health and disease | |
The stress granules component G3BP : functional characterization from KO mouse and identification of its ribonucleoprotein interactome in mouse brain. | |
Study of neuro-cardiac interaction using microfluidic devices and human induced pluripotent stem cells. | |
Study of the modulatory effects of mediterranean plant extracts on T-type calcium channels and the evaluation of their anticonvulsant and antiepileptic activities. | |
T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids. | |
T-type calcium channels are inhibited by fluoxetine and its metabolite norfluoxetine. | |
T-type calcium channels are involved in hypoxic pulmonary hypertension | |
Temperature-dependent modulation of CaV3 T-type calcium channels by protein kinases C and A in mammalian cells. | |
Towards the discovery of novel T-type calcium channel blockers. | |
Transient down-regulation of L-type Ca(2+) channel and dystrophin expression after balloon injury in rat aortic cells |